A clinical study to evaluate the efficacy and safety of Nisha-Amalki capsules in preventing progression to Diabetes in patients with Pre-Diabetes
Phase 4
- Registration Number
- CTRI/2018/08/015503
- Lead Sponsor
- PHARMANZA HERBAL PVT LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Individuals fulfilling one or more laboratory criteria- Fasting blood sugar between 100-125 mg/dl, 2 hours glucose value between 140-199 mg/dl, IDRS (Indian Diabetics Risk score) less than or equal to 60.
2. Those ready to give written informed consent.
Exclusion Criteria
1.Individuals with history of smoking, alcohol or tobacco addiction
2.Those with history of any major illness like hypertension, renal disorders, tuberculosis, epilepsy, neuropathies and psychiatric disorders.
3.Pregnant and lactating women.
4.Those who refused consent to participate in study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method